Literature DB >> 21491083

Ultraviolet exposure of melanoma cells induces fibroblast activation protein-α in fibroblasts: Implications for melanoma invasion.

Petra Wäster1, Inger Rosdahl, Brendan F Gilmore, Oliver Seifert.   

Abstract

Fibroblast activation protein-α (FAP-α) promotes tumor growth and cell invasiveness through extracellular matrix degradation. How ultraviolet radiation (UVR), the major risk factor for malignant melanoma, influences the expression of FAP-α is unknown. We examined the effect of UVR on FAP-α expression in melanocytes, keratinocytes and fibroblasts from the skin and in melanoma cells. UVR induces upregulation of FAP-α in fibroblasts, melanocytes and primary melanoma cells (PM) whereas keratinocytes and metastatic melanoma cells remained FAP-α negative. UVA and UVB stimulated FAP-α-driven migration and invasion in fibroblasts, melanocytes and PM. In co-culture systems UVR of melanocytes, PM and cells from regional metastases upregulated FAP-α in fibroblasts but only supernatants from non-irradiated PM were able to induce FAP-α in fibroblasts. Further, UV-radiated melanocytes and PM significantly increased FAP-α expression in fibroblasts through secretory crosstalk via Wnt5a, PDGF-BB and TGF-β1. Moreover, UV radiated melanocytes and PM increased collagen I invasion and migration of fibroblasts. The FAP-α/DPPIV inhibitor Gly-ProP(OPh)2 significantly decreased this response implicating FAP-α/DPPIV as an important protein complex in cell migration and invasion. These experiments suggest a functional association between UVR and FAP-α expression in fibroblasts, melanocytes and melanoma cells implicating that UVR of malignant melanoma converts fibroblasts into FAP-α expressing and ECM degrading fibroblasts thus facilitating invasion and migration. The secretory crosstalk between melanoma and tumor surrounding fibroblasts is mediated via PDGF-BB, TGF-β1 and Wnt5a and these factors should be evaluated as targets to reduce FAP-α activity and prevent early melanoma dissemination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21491083     DOI: 10.3892/ijo.2011.1002

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways.

Authors:  Sarah K Baird; Laura Allan; Christoph Renner; Fiona E Scott; Andrew M Scott
Journal:  Clin Exp Metastasis       Date:  2015-05-21       Impact factor: 5.150

2.  Bone marrow fibrosis at diagnosis predicts survival for primary acute myeloid leukemia.

Authors:  Z Wu; R Chen; L Wu; L Zou; F Ding; M Wang; X Liu
Journal:  Clin Transl Oncol       Date:  2017-06-06       Impact factor: 3.405

Review 3.  Nanoparticle-mediated drug delivery for treating melanoma.

Authors:  Vaibhav Mundra; Wei Li; Ram I Mahato
Journal:  Nanomedicine (Lond)       Date:  2015-08-05       Impact factor: 5.307

4.  FASN inhibition as a potential treatment for endocrine-resistant breast cancer.

Authors:  Aleksandra Gruslova; Bryan McClellan; Henriette U Balinda; Suryavathi Viswanadhapalli; Victoria Alers; Gangadhara R Sareddy; Tim Huang; Michael Garcia; Linda deGraffenried; Ratna K Vadlamudi; Andrew J Brenner
Journal:  Breast Cancer Res Treat       Date:  2021-04-24       Impact factor: 4.624

Review 5.  Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma.

Authors:  Linli Zhou; Kun Yang; Thomas Andl; R Randall Wickett; Yuhang Zhang
Journal:  J Cancer       Date:  2015-06-23       Impact factor: 4.207

Review 6.  Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).

Authors:  Fuming Zi; Jingsong He; Donghua He; Yi Li; Li Yang; Zhen Cai
Journal:  Mol Med Rep       Date:  2015-01-14       Impact factor: 2.952

7.  UV radiation promotes melanoma dissemination mediated by the sequential reaction axis of cathepsins-TGF-β1-FAP-α.

Authors:  Petra Wäster; Kyriakos Orfanidis; Ida Eriksson; Inger Rosdahl; Oliver Seifert; Karin Öllinger
Journal:  Br J Cancer       Date:  2017-07-11       Impact factor: 7.640

8.  PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach.

Authors:  Daniela D'Arcangelo; Francesco Facchiano; Giovanni Nassa; Andrea Stancato; Annalisa Antonini; Stefania Rossi; Cinzia Senatore; Martina Cordella; Claudio Tabolacci; Annamaria Salvati; Roberta Tarallo; Alessandro Weisz; Angelo M Facchiano; Antonio Facchiano
Journal:  Oncotarget       Date:  2016-11-22

Review 9.  Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape.

Authors:  Veronica Romano; Immacolata Belviso; Alessandro Venuta; Maria Rosaria Ruocco; Stefania Masone; Federica Aliotta; Giuseppe Fiume; Stefania Montagnani; Angelica Avagliano; Alessandro Arcucci
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

10.  Treatment outcomes of advanced stage malignant melanoma in hand and foot after amputation in Korean patients.

Authors:  Kyujin Cho; Sung Taek Jung
Journal:  Clin Orthop Surg       Date:  2013-11-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.